Patients who have a family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome Type 2 are not ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...

UNITED STATES - A new generic treatment option for people with type 2 diabetes has been approved by the FDA. The generic ...

Jaguar's rebrand has been criticized as 'woke.' Marketing experts say it's either 'bonkers' — or a genius disruption.

While avoiding weight gain has long been considered a matter of personal willpower, the rise of "food noise" shows New Year's resolutions are never enough.

Here’s what else you need to know to Get Up to Speed and On with Your Day. The House Ethics Committee found evidence that ...

The US Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over.